Navigation Links
Exploring the 'Davids and Goliaths' of therapeutic molecules
Date:4/8/2010

drug, Gleevec . "Leveraging on our technological know-how and the industry experience of Siena Biotech, we expect our partnership to spark new breakthroughs for cancer research. We especially appreciate the power of collaboration in the dynamic arena of cancer drug discovery."

Large molecule to treat bone diseases

SIgN and Siena Biotech are jointly developing a novel monoclonal antibody applicable to bone diseases such as osteoporosis. Under the agreement, Siena Biotech will characterise, develop and test the effectiveness of the monoclonal antibodies while SIgN will isolate the disease-specific human monoclonal antibody from a pool of tens of billions of polyclonal antibodies.

SIgN and Siena Biotech's antibody is another example of the world-class research being done on targeted disease therapies. The monoclonal antibody is intended to block a specific extracellular component in the molecular pathway that leads to bone loss, and thus stop the disease progression. If successful, it would reduce the risk of bone fractures and hence the associated healthcare costs for those suffering from various forms of bone frailty. Osteoporosis alone is estimated to afflict 1 in 3 women and 1 in 12 men over the age of 50 worldwide.

SIgN Chairman, Prof Philippe Kourilsky commented, "It is thanks to the excellent relationship that Singapore shares with Italy that we can collaborate in the often-neglected area of bone and tissue loss. Together with Siena Biotech, we will be using some of the world's most advanced molecular biology and antibody engineering techniques to hopefully make good progress in this area of research, and meet the dire healthcare needs of the world's ageing population."

"The strong synergies derived from shared commitment and knowledge coupled with complementary technology platforms between ETC, SIgN, and Siena Biotech will accelerate the development of novel therapies in difficult to treat diseases mak
'/>"/>

Contact: Yunshi Wang
wang_yunshi@a-star.edu.sg
656-826-6443
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. GUMCs Lombardi Hosts Symposium Exploring Future of Cancer Research and Personalized Medicine
2. Exploring the limits: Understanding the challenges facing Winter Olympic champions
3. TV Wellness Expert Jillian Michaels Teams With Harley-Davidson to Help Women Channel Their Inner Drive and Live More Fulfilling Lives
4. Massage Envy New Jersey offers $49, 1-Hour Therapeutic Massage
5. How breast cancer cells evade therapeutic attacks
6. Start spreading the news: NYU scientists find therapeutic target to stop cancer metastases
7. Cambridge Healthtech Announces Its Inaugural Encouraging Development of Therapeutics for Neglected Diseases Conference
8. Study says therapeutics for trauma patients may not be effective due to an infection
9. Nitric oxide-releasing wrap for donor organs and cloth for therapeutic socks
10. Castrate-Metastatic Prostate Cancer: Therapeutic Considerations for Advanced Disease
11. Elements Therapeutic Massage Announces Franchise Expansion Plan for Massachusetts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... group at the DFG Research Center for Regenerative Therapies ... (CRTD) demonstrated for the first time the in vitro ... dimensions from mouse embryonic stem cells. Correct spatial organization ... dorsal/ventral axis was observed., This study has been published ... Reports " on 30.10.2014 ., For many years Elly ...
(Date:10/30/2014)... October 30, 2014 Nutrition Leaders, a ... weight loss aids, and more, is currently hosting a ... is already underway, is open to U.S. residents age ... December 15, 2014. One lucky winner will then be ... a $100 gift card to NutritionLeaders.com. , Nutrition Leaders’ ...
(Date:10/30/2014)... 2014 Graphics, coding, typography and search ... the craft of web design and require thorough knowledge ... simpler solution to create a website can be as ... information, customer reviews and Facebook posts all accumulate on ... the next evolution of how a business can develop ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 High ... exclusive concepts in the medical-grade skin care domain: ... development of uniquely potent topical dermatological products, today ... ( http://www.RefinitySkinScience.com ) with patented COSMEDERM®-7 anti-irritant technology. ... acid concentrations (50% and 70%) and a low ...
(Date:10/30/2014)... PreDiabetes Centers , the pioneer ... shoppers with a supply of sugardown®, a chewable dietary ... blood sugar spikes. Learning how to control blood sugar ... of a diabetes prevention plan. , Shoppers who spend ... tube of sugardown. The offer expires November 30. ...
Breaking Medicine News(10 mins):Health News:Reconstruction of a patterned piece of spinal cord in 3-D culture 2Health News:Nutrition Leaders Announces Gift Card Sweepstakes 2Health News:Facebook Websites In Thirty-Seconds 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 3Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 4Health News:PreDiabetes Treatment Company Offers PreD Store Shoppers Supplements to Support Healthy Blood Sugar 2
... , This release is available in German ... in Health Care (IQWiG) has investigated the reliability of diagnosing ... and the benefit that the test results can have for ... According to the report, the available studies do not reveal ...
... detect brain damage in amateur boxers. Deterioration of nerve cells ... This is shown in a new study from the Sahlgrenska ... results of the study conducted by researchers at the Sahlgrenska ... published in the current issue of the scientific journal ...
... shown that patients who receive night home hemodialysis live ... from deceased donors. In a study entitled, ... transplant recipients," published in the international September issue of ... patients were followed for up to 12 years. Night ...
... , , , NEW ORLEANS, Aug. 20 ... the Rouses Market, 4500 Tchoupitoulas Street , Ochsner ... R o uses Markets, the largest independent grocer in Louisiana, will announce ... www.cho o se-healthy.org ." ...
... them individually, study finds , THURSDAY, Aug. 20 (HealthDay ... one nostril detects scents slightly differently than the other, ... in perception result from small differences in the time ... or the other. They call the difference a "binaural" ...
... disorientation occurs quickly without the sun, moon for guidance, , ... losing their way in the wilderness, unwittingly walking in circles ... are true. Without the sun, a compass or a landmark, ... or a desert ended up back where they started, according ...
Cached Medicine News:Health News:Reliability and benefit of diagnostic procedure for asthma in young children is unclear 2Health News:Reliability and benefit of diagnostic procedure for asthma in young children is unclear 3Health News:Reliability and benefit of diagnostic procedure for asthma in young children is unclear 4Health News:Blood test can detect brain damage in amateur boxers 2Health News:Night home hemodialysis shown to be as good as transplant in treating kidney failure 2Health News:Ochsner and Rouses Markets Partner for Choose Healthy Initiative 2Health News:Ochsner and Rouses Markets Partner for Choose Healthy Initiative 3Health News:Nostrils Compete to Relay Key Fragrance 2Health News:Lost Hikers, Backpackers Really Do Walk in Circles 2Health News:Lost Hikers, Backpackers Really Do Walk in Circles 3
(Date:10/30/2014)... 30, 2014  Electronic health records uptake in ... of government initiatives and the considerable resources – ... invested over the past five years. Electronic health ... and U.S. clinicians use them on a daily ... Frost & Sullivan,s newest ...
(Date:10/30/2014)... 2014  Nektar Therapeutics (Nasdaq: NKTR ) ... ended September 30, 2014 on Thursday, November 6, 2014, ... Robin , president and chief executive officer, will host ... 5:00 p.m. Eastern Time (ET)/2:00 p.m. Pacific Time (PT). ... audio-only Webcast of the conference call can be accessed ...
(Date:10/30/2014)... 2014  CytRx Corporation (NASDAQ: CYTR ... in oncology, today announced an upcoming presentation highlighting ... aldoxorubicin.  The presentation, titled, "Drug Conjugates Bind Covalently ... by Sant P. Chawla , M.D., F.R.A.C.P., ... investigator of the Company,s ongoing global, pivotal Phase ...
Breaking Medicine Technology:Electronic Health Record Usability: CIOs Weigh In 2Electronic Health Record Usability: CIOs Weigh In 3Electronic Health Record Usability: CIOs Weigh In 4Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets 2CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 2CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 3CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 4
Dual offset femoral stems, hip stems that provide unique and competitive features....
Cementless hip stem revisions offering optimal version setting for each patient. Compatible with modular link ceramic or cobalt chromium femoral heads with up to 4 neck lengths, or the link saddle de...
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
Medicine Products: